Phase II trial of maytansine in patients with advanced colorectal carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008453:Maytansine / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010078:Oxazines / Q000627:therapeutic use*; D012004:Rectal Neoplasms / Q000188:drug therapy*
D010078:Oxazines; D008453:Maytansine